Eight Pennsylvania colleges get OK to study medical marijuana

(This story has been updated from an earlier version.)

Pennsylvania on Monday unveiled eight universities that will be allowed to research medical marijuana, a potential boon for an industry where cannabis study is extremely limited.

According to the Tribune-Review, the schools authorized to conduct MMJ research are:

  • Drexel University College of Medicine, Philadelphia
  • Lake Erie College of Osteopathic Medicine, Erie
  • Lewis Katz School of Medicine at Temple University, Philadelphia
  • Penn State College of Medicine, Hershey
  • Perelman School of Medicine at the University of Pennsylvania, Philadelphia
  • Philadelphia College of Osteopathic Medicine
  • Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia
  • University of Pittsburgh School of Medicine

Monday’s announcement by Pennsylvania Gov. Tom Wolf is unusual because few state cannabis programs have made such a commitment to studying medical cannabis.

But research is sorely needed in a space where a lack of scientific studies into the medical benefits of cannabis has slowed the growth of the industry.

Here’s what you need to know:

  • The eight “certified academic clinical research centers” will research the efficacy and safety of medical cannabis for treating several health conditions.
  • Each center will partner with a cannabis company that will be granted one state license to cultivate and process MMJ. The company will also receive a dispensary license to sell medical cannabis at up to six storefronts.
  • A legal challenge filed by some MMJ license holders is still pending, according to the Pittsburgh Post-Gazette. A group of license holders filed an injunction to stop Pennsylvania’s research program, arguing that it will provide an unfair advantage to the partner company.

Latest Headlines

4 comments on “Eight Pennsylvania colleges get OK to study medical marijuana
  1. Mike on

    The real public good of actual research massively overwhelms some hypothetical advantage to the one company growing for the schools.

    • Eric Layland on

      100% agree. As an industry cannabis needs to focus on the greater good vs. maximizing shareholder value.

  2. Mark on

    How this happening without DOJ and DEA approvals?
    All those requests for doing MMJ research that have been sitting on Sessions desk; he sign off in them all?
    And universities have been so hesitant because of fed funds and loans that flow through for univ
    operations. That all been resolved? That all a non issue ar these universities??

  3. Joe on

    Considering that soon there will be 25 grower/processors and 150 dispensaries throughout Pa, and all results are tracked by the state MJ Freeway System, why not require the universities to partner with those that are apparently qualified and earned their licenses, rather than create another 8 growers and 48 dispensaries, that will have an unfair advantage due to their alignment with medical universities. Let’s provide those that qualified the opportunity to partner with the universities and bring real purpose to their delivery of product to targeted patients. Protect the companies that earned their licenses and are spending millions to prepare to go to market. This will grant the universities the opportunity to work with all or a select number of growers and the right to deliver product to all dispensaries in their regions, thereby helping those already qualified succeed.

Leave a Reply

Your email address will not be published. Required fields are marked *